• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

    10/10/23 8:19:59 AM ET
    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Building Products
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AUVI alert in real time by email

    Gainers

    SuperCom Ltd. (NASDAQ:SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.

    Immunic, Inc. (NASDAQ:IMUX) shares gained 13.2% to $1.80 in pre-market trading after the company disclosed positive interim data from Phase 2 CALLIPER trial of vidofludimus calcium in progressive multiple sclerosis.

    Tempest Therapeutics, Inc. (NASDAQ:TPST) shares rose 21.1% to $0.2785 in pre-market trading, after falling 8% on Monday.

    Mobilicom Limited (NASDAQ:MOB) rose 41.1% to $2.05 in pre-market trading, after gaining more than 11% on Monday.

    SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares climbed 18.2% to $2.01 in pre-market trading, after jumping 18% on Monday. Domaine Des Massifs and SMX recently formed a strategic collaboration to revolutionize traceability.

    ContraFect Corporation (NASDAQ:CFRX) rose 16.8% to $0.5277 in pre-market trading, after surging more than 12% on Monday.

    ParaZero Technologies Ltd. (NASDAQ:PRZO) shares jumped 13.8% to $3.07 in pre-market trading. ParaZero Technologies shares jumped 133% on Monday after the company announced an Australian regulator approved the first commercial drone flights in populated areas and near people using the ParaZero safety systems.

    Sonendo, Inc. (NYSE:SONX) gained 11.2% to $0.4172 in pre-market trading, after gaining 23% on Monday. Sonendo recently revealed a Receipt of notice of non-compliance with the NYSE Trading Share Price Listing Rule.

    Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares surged 11% to $1.11 in pre-market trading. Lexicon Pharmaceuticals said INPEFA received preferred formulary status with Express Scripts for Medicare patients.

    ReTo Eco-Solutions, Inc. (NASDAQ:RETO) shares rose 9% to $0.58 in pre-market trading. ReTo Eco-Solutions recently reported a $15 million registered direct offering and $10 million concurrent private placement.

    Losers

    Borqs Technologies, Inc. (NASDAQ:BRQS) fell 50.8% to $0.52 in pre-market trading after declining more than 13% on Monday. Borqs Technologies recently announced a 1-for-12 reverse stock split.

    Phoenix Motor Inc. (NASDAQ:PEV) fell 14.6% to $1.35 in pre-market trading, after surging 58% on Monday. Phoenix Motor said its EdisonFuture subsidiary launched new Proton Exchange Membrane (PEM) solutions for green hydrogen products and production.

    Atreca, Inc. (NASDAQ:BCEL) shares fell 12.8% to $0.2011 in pre-market trading.

    RVL Pharmaceuticals plc (NASDAQ:RVLP) shares fell 11.4% to $0.1689 in pre-market trading, after jumping over 50% on Monday.

    Molekule Group, Inc. (NASDAQ:MKUL) shares fell 10.2% to $0.1158 in pre-market trading after gaining around 5% on Monday.

    Windtree Therapeutics, Inc. (NASDAQ:WINT) fell 9.9% to $1.09 in pre-market trading.

    Applied UV, Inc. (NASDAQ:AUVI) shares fell 9.8% to $0.3121 in pre-market trading. The company recently announced its new product, the Airocide Pro+ air purification system for food preservation, which will be on display at the Global Produce & Floral Show.

    Vascular Biogenics Ltd. (NASDAQ:VBLT) fell 9.1% to $0.2272 in pre-market trading. Vascular Biogenics, during August, posted a narrower loss for the second quarter.

    Maison Solutions Inc. (NASDAQ:MSS) fell 9.2% to $5.90 in pre-market, after dipping 11% on Monday.

    Future FinTech Group Inc. (NASDAQ:FTFT) shares fell 8.7% to $0.95 in pre-market trading.

    Now Read This: Walgreens Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $AUVI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AUVI
    $BCEL
    $BRQS
    $CFRX

    CompanyDatePrice TargetRatingAnalyst
    Immunic Inc.
    $IMUX
    4/17/2026$2.50Buy
    Stifel
    Immunic Inc.
    $IMUX
    4/15/2026Buy → Hold
    D. Boral Capital
    Immunic Inc.
    $IMUX
    3/24/2026$7.00Buy
    Guggenheim
    Tempest Therapeutics Inc.
    $TPST
    1/22/2026$11.00Neutral → Buy
    H.C. Wainwright
    Immunic Inc.
    $IMUX
    11/7/2025$3.00Buy
    Roth Capital
    Immunic Inc.
    $IMUX
    9/29/2025$13.00Buy
    Chardan Capital Markets
    Tempest Therapeutics Inc.
    $TPST
    4/10/2025Sector Outperform → Sector Perform
    Scotiabank
    Tempest Therapeutics Inc.
    $TPST
    4/10/2025Buy → Neutral
    H.C. Wainwright
    More analyst ratings

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    SEC Filings

    View All

    SEC Form 6-K filed by Mobilicom Limited

    6-K - Mobilicom Ltd (0001898643) (Filer)

    4/23/26 9:17:13 AM ET
    $MOB
    Aerospace
    Industrials

    Immunic Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - IMMUNIC, INC. (0001280776) (Filer)

    4/23/26 8:30:43 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by ParaZero Technologies Ltd.

    6-K - ParaZero Technologies Ltd. (0001916241) (Filer)

    4/23/26 8:20:25 AM ET
    $PRZO
    Military/Government/Technical
    Industrials

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Mobilicom to Exhibit at Modern Day Marine 2026, Showcasing its Cybersecure Solutions Portfolio Amid Growing U.S. Department of War Platform Deployments

    Mobilicom to hold strategic meetings with U.S. Department of War and Marine Corps representatives, as well as existing customers and new customers under integration, at the premier Marine Corps technology exposition Palo Alto, California, April 23, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (NASDAQ:MOB, MOBBW)) ("Mobilicom" or the "Company"), a provider of cybersecurity and robust solutions for drones and robotics, today announced it will exhibit at Modern Day Marine 2026, taking place April 28–30, 2026 in Washington, D.C. The Company will exhibit under the booth of its strategic U.S. partner, Noble, a leading provider of procurement and logistics for the defense industry, at Booth #618.

    4/23/26 9:15:00 AM ET
    $MOB
    Aerospace
    Industrials

    A $550 Billion Opportunity: Drones-as-a-Service Emerges as Defense's Next Growth Engine

    Governments are accelerating investments in scalable autonomous drone operations without the burden of fleet ownershipMarket News Updates News Commentary CounterNEW YORK, April 23, 2026 /CNW/ -- Drones-as-a-Service (DaaS) is quickly becoming a major shift in how military and defense organizations actually use drone technology in the field. Instead of spending heavily to purchase and maintain their own fleets, agencies can now tap into drone capabilities like aerial surveillance, mapping, logistics delivery, and ISR (intelligence, surveillance, and reconnaissance) whenever they're needed. It works a lot like a cloud subscription model—giving operators access to the latest hardware, AI-powered

    4/23/26 9:00:00 AM ET
    $PRZO
    $RCAT
    $UAVS
    Military/Government/Technical
    Industrials
    Computer Software: Prepackaged Software
    Technology

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Xu John bought $2,958 worth of shares (23,400 units at $0.13), increasing direct ownership by 0.20% to 11,827,400 units (SEC Form 4)

    4 - Maison Solutions Inc. (0001892292) (Issuer)

    4/23/26 9:42:00 PM ET
    $MSS
    Food Chains
    Consumer Staples

    Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/27/26 8:33:21 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $147,000 worth of shares (100,000 units at $1.47), increasing direct ownership by 6% to 1,904,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/25/26 7:00:27 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Immunic with a new price target

    Stifel initiated coverage of Immunic with a rating of Buy and set a new price target of $2.50

    4/17/26 8:12:09 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Immunic downgraded by D. Boral Capital

    D. Boral Capital downgraded Immunic from Buy to Hold

    4/15/26 7:47:45 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on Immunic with a new price target

    Guggenheim initiated coverage of Immunic with a rating of Buy and set a new price target of $7.00

    3/24/26 8:40:25 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Xu John bought $2,958 worth of shares (23,400 units at $0.13), increasing direct ownership by 0.20% to 11,827,400 units (SEC Form 4)

    4 - Maison Solutions Inc. (0001892292) (Issuer)

    4/23/26 9:42:00 PM ET
    $MSS
    Food Chains
    Consumer Staples

    SEC Form 3 filed by new insider Trabelsi Barak

    3 - SuperCom Ltd (0001291855) (Issuer)

    4/20/26 5:30:18 PM ET
    $SPCB
    Semiconductors
    Technology

    SEC Form 3 filed by new insider Trabelsi Ordan

    3 - SuperCom Ltd (0001291855) (Issuer)

    4/15/26 9:00:25 PM ET
    $SPCB
    Semiconductors
    Technology

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Leadership Updates

    Live Leadership Updates

    View All

    Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

    Adds dedicated business development leadership to support Tempest's strategic prioritiesWill lead China outreach and cross-border partnership effortsTo support ongoing partnering discussions for Phase 3-ready amezalpat program, including potential China development opportunities BRISBANE, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today announced the appointment of Andrew Fang, Ph.D., as Head of Business Development. Dr. Fang will lead Tempest's global business development efforts, including strategic partners

    4/14/26 8:00:00 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton

    – Nearly 40-Year Biopharmaceutical Professional with Deep CNS and Commercial Leadership Experience in Multiple Sclerosis –– Served on Original Team Responsible for the Launch of Copaxone® in the United States –NEW YORK, March 31, 2026 /PRNewswire/ -- Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced the appointment of Jon Congleton, a seasoned biopharmaceutical executive with nearly 40 years of experience spanning drug development, commercialization and corporate leadership, to its Board of Directors, effective March 27, 2026.Mr. Congleton has a strong track record of building and leadin

    3/31/26 6:30:00 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Financials

    Live finance-specific insights

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Mobilicom Reports 2025 Year-End Financial Results

    A Mobilicom Tier-1 defense customer won a U.S. Department of War (DoW) Program of Record, indicating a potential production scale orders for the next 5 years  Cash and cash equivalents surge 120% to $19.1 million following $12.6 million in 2025 warrants exercise and equity raises With revenues up year-over-year at $3.4 million, monthly operating cash burn was cut by 41% to ~$159K — lowest in Company history — with zero-debt on balance sheet Launch of industry-first Secured Autonomy™ cybersecurity framework, multiple new design wins across Europe, Middle East and South Asia, and expanded U.S. Tier-1 drone production-scale orders drive multi-market momentum Webcast scheduled for 4:30 pm E

    3/23/26 4:06:00 PM ET
    $MOB
    Aerospace
    Industrials

    Mobilicom to Report Full Year 2025 Financial and Operating Results on March 23, 2026

    Palo Alto, California, March 16, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (NASDAQ:MOB, MOBBW), MOBBW) ("Mobilicom" or the "Company"), a provider of cybersecurity and robust solutions for drones and robotics, today announced that it will issue a press release with its financial and operational results for the twelve months ended December 31, 2025 before the Nasdaq Stock Market opens on Monday, March 23, 2026. The Company will also discuss its results and other corporate developments, followed by a Q&A session, on a conference call at 4:30 p.m. EST the same day. Investors are invited to email questions to the Company in advance to: [email protected]. Conference call & webcast info: Monda

    3/16/26 8:00:00 AM ET
    $MOB
    Aerospace
    Industrials

    $AUVI
    $BCEL
    $BRQS
    $CFRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:32:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:31:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials